Cam Gallagher
Director · Opus Genetics, Inc.
IndividualBuying only
- 2025
- Sep 8, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Cam Gallagher files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Foundation Fighting Blindness Retinal Degeneration Fund - $10.15M in IRD purchases and sales in the last 12 months
- George Magrath - $205K in IRD purchases and sales in the last 12 months
- Robert E. Gagnon - $191K in IRD purchases and sales in the last 12 months
- Benjamin R. Yerxa - $61K in IRD purchases and sales in the last 12 months
- Ashwath Jayagopal - $58K in IRD purchases and sales in the last 12 months
- Joseph K. Schachle - $58K in IRD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Cam Gallagher?
Cam Gallagher is a corporate insider, tracked as Director of Opus Genetics, Inc. (IRD). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Cam Gallagher submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Cam Gallagher been buying or selling stock?
Recorded transactions: 2 open-market purchases ($324K) and 0 open-market sales across all tracked filings.
